Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2006 (2006), Article ID 14869, 4 pages
http://dx.doi.org/10.1155/IDOG/2006/14869
Clinical Study

Symptom Exacerbation and Adherence to Antiretroviral Therapy During the Menstrual Cycle: A Pilot Study

1School of Public Health, University of Texas Health Science Center at Houston, RAS 319, PO Box 20186, Houston, TX 77225, USA
2College of Osteopathic Medicine, Kansas City University of Medicine and Biosciences, Kansas City, MO 64106-1453, USA

Received 15 March 2005; Revised 31 March 2005; Accepted 31 May 2005

Copyright © 2006 Pinaki N. Patel and Richard M. Grimes. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Our objective is to investigate the relationship between drug and menstrual cycle symptoms in HIV+ women receiving antiretroviral therapy (HAART). Interviews were done for 12 weeks with 54 HIV+ women receiving HAART. Patients were asked if they experienced any of 28 symptoms associated with HAART and the menstrual cycle and about HAART adherence. Weeks were divided into menstrual weeks (MWs), premenstrual weeks (PWs), and other weeks. Women reported more bloating (P=.02) and cramps (P=.001) during MWs. Skin problems (P=.08) and breast tenderness (P=.03) were experienced during PWs. Feeling tired/loss of energy (P=.05), joint pain (P=.02), and chills (P=.03) were higher in non-MW/PWs. Women were slightly less adherent during the MWs (89%) than PWs (94%) and other weeks (93%). Feeling sad or depressed (P=.01) was associated with nonadherence. Experiencing certain symptoms associated with both the menstrual cycle and HAART drugs was related with nonadherence.